Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study

BACKGROUND: Patients with V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E-mutated advanced colorectal cancer (CRC) have a poor prognosis, and treatment options that can improve outcome are still under investigation. The purpose of this study was to discuss the differences of overall surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Qianhao, Zhao, Jian, Yu, Yuanyuan, Wang, Ke, Ren, Jing, Xu, Chang, Wang, Yusheng, Wang, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969634/
https://www.ncbi.nlm.nih.gov/pubmed/36849918
http://dx.doi.org/10.1186/s12885-023-10640-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969634/
https://www.ncbi.nlm.nih.gov/pubmed/36849918
http://dx.doi.org/10.1186/s12885-023-10640-9

Ejemplares similares